Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673347 · ClinicalTrials.gov registry record · Phase 3
Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe
A Phase 3 study of Osteoarthritis, sponsored by Paul Fortin, MD.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01673347 is a Phase 3 study of Osteoarthritis that has completed, run by Paul Fortin, MD. The registered enrollment target is 24 participants, below the 818-participant average among 135 other Osteoarthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01673347, a Phase 3 study of Osteoarthritis, has completed, sponsored by Paul Fortin, MD.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe.
Conditions Studied
Interventions
- BIOLOGICAL Meniscal Allograft
Study Locations (1)
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-09 |
| Est. Completion | 2017-03-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673347
The ClinicalTrials.gov registry entry for NCT01673347 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 135 other Osteoarthritis trials with a reported enrollment target (97% lower). The listed sponsor is Paul Fortin, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Meniscal Allograft is the first listed.
NCT01673347 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01673347 about?
NCT01673347 is a clinical study titled "Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe". Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe.
What is the current status of trial NCT01673347?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2010-09. Estimated completion is 2017-03-10.
What conditions does trial NCT01673347 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT01673347?
The interventions under investigation include: Meniscal Allograft (BIOLOGICAL).
Who is sponsoring clinical trial NCT01673347?
This trial is sponsored by Paul Fortin, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01673347 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Beat Pain Better Trial
RECRUITING · Phase 3
-
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
RECRUITING · Phase 3
-
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
COMPLETED · Phase 3
-
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
COMPLETED · Phase 3
-
Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.